| Literature DB >> 22453048 |
Emmanuel Arinaitwe1, Anne Gasasira, Wendy Verret, Jaco Homsy, Humphrey Wanzira, Abel Kakuru, Taylor G Sandison, Sera Young, Jordan W Tappero, Moses R Kamya, Grant Dorsey.
Abstract
BACKGROUND: In sub-Saharan Africa, malnutrition and malaria remain major causes of morbidity and mortality in young children. There are conflicting data as to whether malnutrition is associated with an increased or decreased risk of malaria. In addition, data are limited on the potential interaction between HIV infection and the association between malnutrition and the risk of malaria.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22453048 PMCID: PMC3337276 DOI: 10.1186/1475-2875-11-90
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Study profile.
Characteristics of study participants
| Characteristic | Risk group | ||
|---|---|---|---|
| HIV-unexposed (n = 99) | HIV-exposed (n = 202) | HIV-infected (n = 57) | |
| Female gender, n (%) | 40 (40%) | 101 (50%) | 28 (49%) |
| Residence in urban area, n (%) | 23 (23%) | 39 (19%) | 18 (32%) |
| Median duration of follow-up, months (IQR) | 15.2 (12.1-17.5) | 16.7 (13.4-19.5) | 14.3 (11.8-18.4) |
| Mean age during follow-up, months (SD) | 14.3 (2.0) | 13.2 (2.8) | 14.3 (3.1) |
| Proportion of follow-up time prescribed TS | 0 | 73% | 100% |
| Proportion of follow-up time breastfeeding | 81% | 24% | 64% |
| Mean HAZ scores | |||
| Mild stunting, n (%) | 38 (38%) | 71 (35%) | 17 (30%) |
| Moderate-severe stunting, n (%) | 28 (28%) | 69 (34%) | 29 (51%) |
| Mean WAZ scores | |||
| Mild underweight | 23 (23%) | 52 (26%) | 13 (23%) |
| Moderate-severe underweight | 7 (7.1%) | 21 (10%) | 17 (30%) |
Figure 2Relationship between mean height-for-age Z scores (HAZ) and weight-for-age Z scores (WAZ) across age stratified by HIV status (using lowess smoothing).
Variables associated with measures of malnutrition
| Variable | Proportion with z-score < -1 | Unadjusted RR* (95% CI) | p-value | Adjusted RR** (95% CI) | p-value | |
|---|---|---|---|---|---|---|
| Exposed group† | Unexposed group | |||||
| Stunting (HAZ-score) | ||||||
| Breastfeeding | 52% | 73% | 0.70 (0.64-0.76) | < 0.001 | 0.75 (0.69-0.82) | < 0.001 |
| HIV-infected | 79% | 62% | 1.34 (1.16-1.54) | < 0.001 | 1.38 (1.18-1.62) | < 0.001 |
| TS chemoprophylaxis | 59% | 71% | 0.78 (0.71-0.85) | < 0.001 | 0.82 (0.74-0.90) | < 0.001 |
| Urban vs. rural residence | 57% | 65% | 0.87 (0.73-1.04) | 0.12 | 0.87 (0.74-1.03) | 0.10 |
| Being underweight (WAZ-score) | ||||||
| Breastfeeding | 34% | 37% | 0.89 (0.78-1.01) | 0.08 | 0.89 (0.78-1.02) | 0.09 |
| HIV infected | 49% | 34% | 1.48 (1.09-2.01) | 0.01 | 1.41 (1.02-1.96) | 0.04 |
| TS chemoprophylaxis | 37% | 34% | 1.06 (0.90-1.25) | 0.49 | 1.06 (0.89-1.27) | 0.52 |
| Urban vs. rural residence | 33% | 36% | 0.91 (0.66-1.26) | 0.57 | 0.88 (0.65-1.21) | 0.45 |
† Exposed groups include breastfeeding, HIV infected participants, TS chemoprophylaxis, and urban residence
*RR relative risk using univariate analysis including only the variable of interest
**RR relative risk using multivariate analysis including all variables of interest listed in the table
Variables associated with the incidence of malaria
| Variable | Incidence of malaria | Unadjusted IRR* (95% CI) | p-value | Adjusted IRR** (95% CI) | p-value | |
|---|---|---|---|---|---|---|
| Exposed† | Unexposed | |||||
| Measures of stunting | ||||||
| none | - | 2.87 | reference | - | reference | - |
| mild | 4.02 | - | 1.55 (1.31-1.83) | < 0.001 | 1.24 (1.06-1.46) | -0.008 |
| moderate-severe | 3.89 | - | 1.64 (1.37-1.98) | < 0.001 | 1.24 (1.03-1.48) | 0.02 |
| Breastfeeding | 2.93 | 4.02 | 0.56 (0.50-0.63) | < 0.001 | 0.85 (0.68-1.07) | 0.17 |
| HIV infected | 2.06 | 3.91 | 0.56 (0.43-0.75) | < 0.001 | 0.93 (0.67-1.30) | 0.68 |
| TS chemoprophylaxis | 2.18 | 5.05 | 0.38 (0.33-0.43) | < 0.001 | 0.50 (0.41-0.61) | < 0.001 |
| Urban vs. rural residence | 1.65 | 4.19 | 0.41 (0.31-0.52) | < 0.001 | 0.44 (0.34-0.56) | < 0.001 |
| Age per 1 year increase | N/A | 2.22 (2.01-2.44) | < 0.001 | 1.49 (1.20-1.84) | < 0.001 | |
† Exposed groups include stunted, breastfeeding, HIV infected participants, TS chemoprophylaxis, and urban residence
* IRR incidence rate ratio using univariate analysis including only the variable of interest
**IRR incidence rate ratio using multivariate analysis including all variables of interest listed in the table